KLF2 and persistent truncus arteriosus: Therefore, we further examined whether endothelial inhibition of Klf2 in vivo by targeted delivery of Klf2-siRNA with RGD-peptide magnetic nanoparticles into cardiac microvasculature ECs contributes to the improvement of simvastatin on TAC-induced cardiac dysfunction.